118 related articles for article (PubMed ID: 26322949)
1. One-Step Ligation on RNA Amplification for the Detection of Point Mutations.
Zhang L; Wang J; Coetzer M; Angione S; Kantor R; Tripathi A
J Mol Diagn; 2015 Nov; 17(6):679-88. PubMed ID: 26322949
[TBL] [Abstract][Full Text] [Related]
2. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.
Beck IA; Mahalanabis M; Pepper G; Wright A; Hamilton S; Langston E; Frenkel LM
J Clin Microbiol; 2002 Apr; 40(4):1413-9. PubMed ID: 11923366
[TBL] [Abstract][Full Text] [Related]
3. Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay.
Villahermosa ML; Beck I; Pérez-Alvarez L; Contreras G; Frenkel LM; Osmanov S; de Parga EV; Delgado E; Manjon N; Cuevas MT; Thomson MM; Medrano L; Najera R
J Hum Virol; 2001; 4(5):238-48. PubMed ID: 11907381
[TBL] [Abstract][Full Text] [Related]
4. Detection of point mutations with a modified ligase chain reaction (Gap-LCR).
Abravaya K; Carrino JJ; Muldoon S; Lee HH
Nucleic Acids Res; 1995 Feb; 23(4):675-82. PubMed ID: 7534908
[TBL] [Abstract][Full Text] [Related]
5. Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.
Vega Y; Pérez-Alvárez L; Delgado E; Muñoz M; Casado G; Carmona R; Sierra M; Vázquez de Parga E; Pinilla M; García V; Medrano L; Contreras G; Thomson M; Nájera R
J Clin Microbiol; 2005 Oct; 43(10):5301-4. PubMed ID: 16208003
[TBL] [Abstract][Full Text] [Related]
6. Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies.
Lalonde MS; Troyer RM; Syed AR; Bulime S; Demers K; Bajunirwe F; Arts EJ
J Clin Microbiol; 2007 Aug; 45(8):2604-15. PubMed ID: 17567789
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.
Beck IA; Crowell C; Kittoe R; Bredell H; Machaba M; Willamson C; Janssens W; Jallow S; van der Groen G; Shao Y; Jacob M; Samuel NM; de Rivera IL; Ngo-Giang-Huong N; Cassol S; Alemnji G; Frenkel LM
J Acquir Immune Defic Syndr; 2008 Aug; 48(4):418-27. PubMed ID: 18614915
[TBL] [Abstract][Full Text] [Related]
8. Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation.
Panpradist N; Beck IA; Chung MH; Kiarie JN; Frenkel LM; Lutz BR
PLoS One; 2016; 11(1):e0145962. PubMed ID: 26751207
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
Dokuta S; Utaipat U; Praparattanapan J; Keitkarn J; Maneekarn N; Sirisanthana T; Supparatpinyo K
J Virol Methods; 2013 Jun; 190(1-2):20-8. PubMed ID: 23562659
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors.
Wallis CL; Mahomed I; Morris L; Chidarikire T; Stevens G; Rekhviashvili N; Stevens W
J Virol Methods; 2005 May; 125(2):99-109. PubMed ID: 15794978
[TBL] [Abstract][Full Text] [Related]
11. Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing.
Beck IA; Deng W; Payant R; Hall R; Bumgarner RE; Mullins JI; Frenkel LM
J Clin Microbiol; 2014 Jul; 52(7):2320-7. PubMed ID: 24740080
[TBL] [Abstract][Full Text] [Related]
12. Detection of residual human immunodeficiency virus type 1 reverse transcriptase K103N minority species in plasma RNA and peripheral blood mononuclear cell DNA following discontinuation of non-nucleoside therapy.
Saladini F; Vicenti I; Razzolini F; Zazzi M
Clin Microbiol Infect; 2010 Jul; 16(7):848-51. PubMed ID: 19681953
[TBL] [Abstract][Full Text] [Related]
13. Nonradiometric ELISA-based quantitation and validation of polymerase chain reaction-amplified DNA, including detection of point mutations, without allele-specific amplification, or ligation.
Miele L; Peri A; Cordella-Miele E; Mukherjee AB
DNA Cell Biol; 1994 Dec; 13(12):1233-42. PubMed ID: 7529025
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of the HIV type 1 reverse transcriptase codon T215Y by reverse transcription-polymerase chain reaction with fluorogenic probes.
Ross L; Vavro C; Zimmermann A; St Clair M
AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1287-92. PubMed ID: 10505677
[TBL] [Abstract][Full Text] [Related]
15. A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
Troyer RM; Lalonde MS; Fraundorf E; Demers KR; Kyeyune F; Mugyenyi P; Syed A; Whalen CC; Bajunirwe F; Arts EJ
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):235-50. PubMed ID: 18284323
[TBL] [Abstract][Full Text] [Related]
16. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
[TBL] [Abstract][Full Text] [Related]
17. Sensitive detection of the K103N non-nucleoside reverse transcriptase inhibitor resistance mutation in treatment-naïve HIV-1 infected individuals by rolling circle amplification.
Wang B; Dwyer DE; Chew CB; Kol C; He ZP; Joshi H; Steain MC; Cunningham AL; Saksena NK
J Virol Methods; 2009 Oct; 161(1):128-35. PubMed ID: 19523982
[TBL] [Abstract][Full Text] [Related]
18. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
[TBL] [Abstract][Full Text] [Related]
19. Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART).
Morabito K; Kantor R; Tai W; Schreier L; Tripathi A
J Mol Diagn; 2013 May; 15(3):401-12. PubMed ID: 23541840
[TBL] [Abstract][Full Text] [Related]
20. Chimeric padlock and iLock probes for increased efficiency of targeted RNA detection.
Krzywkowski T; Kühnemund M; Nilsson M
RNA; 2019 Jan; 25(1):82-89. PubMed ID: 30309880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
